tiprankstipranks
FibroGen (FGEN)
NASDAQ:FGEN

FibroGen (FGEN) Financial Statements

908 Followers

FibroGen Financial Overview

FibroGen's market cap is currently ―. The company's EPS TTM is $-2.448; its P/E ratio is -0.28; FibroGen is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 55.90M$ 27.14M$ 40.13M$ 23.89M$ 24.16M
Gross Profit$ 30.15M$ 21.73M$ 35.89M$ 44.32M$ 32.67M
EBIT$ -28.49M$ -51.70M$ -59.19M$ -79.69M$ -75.06M
EBITDA$ -27.67M$ -49.82M$ -58.65M$ -78.10M$ -72.78M
Net Income Common Stockholders$ -32.93M$ -56.23M$ -67.91M$ -87.68M$ -77.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 177.60M$ 235.59M$ 251.34M$ 335.72M$ 355.95M
Total Assets$ 365.87M$ 423.53M$ 460.43M$ 515.13M$ 538.54M
Total Debt$ 149.96M$ 152.55M$ 153.59M$ 156.23M$ 86.81M
Net Debt$ -27.64M$ -83.04M$ -97.75M$ -179.48M$ -269.14M
Total Liabilities$ 552.02M$ 585.73M$ 575.63M$ 575.43M$ 567.43M
Stockholders Equity$ -228.12M$ -204.17M$ -157.17M$ -102.27M$ -48.85M
Cash Flow-
Free Cash Flow$ -59.32M$ -18.57M$ -85.22M$ -111.56M$ -102.18M
Operating Cash Flow$ -59.29M$ -18.32M$ -84.54M$ -110.57M$ -101.59M
Investing Cash Flow$ 51.28M$ 10.24M$ 54.22M$ -14.29M$ 103.48M
Financing Cash Flow$ -165.00K$ -246.00K$ -22.00K$ 91.53M$ 31.48M
Currency in USD

FibroGen Earnings and Revenue History

FibroGen Debt to Assets

FibroGen Cash Flow

FibroGen Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis